Found 175 matching trials
Effect of Cladribine Treatment on Microglial Activation in the CNS N/A To evaluate the effect of cladribine treatment on microglial activation wit...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) PHASE3 The purpose of the study is to determine if cladribine tablets are a safe a...
Show More Location
Multiple Locations
Learn More & Join Trial
Cladribine in Combination With GAP in Patients With Refractory/Relapsed Acute Lymphoblastic Leukemia PHASE2 The vast majority of patients with ALL will die of the disease, and no stan...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia PHASE2 The vast majority of patients with AML will die of the disease, and no stan...
Show More Learn More & Join Trial
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia NA This pilot clinical trial studies the feasibility of choosing treatment bas...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Oral Cladribine B-cell Study N/A To study the impact of cladribine on peripheral and intrathecal B-cell, pla...
Show More Location
Barts Health NHS Trust
Learn More & Join Trial
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma PHASE2 Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia PHASE2 CLAG-M is an active, well tolerated regimen in acute myelogenous leukemia. ...
Show More Location
Westchester Medical Center/New York Medical College
Learn More & Join Trial
A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old PHASE3 The study will include newly-diagnosed AML patients, not suffering acute pr...
Show More Location
Weill Cornell Medicine
Learn More & Join Trial
ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis PHASE2 MS is a chronic inflammatory and degenerative disease of the central nervou...
Show More Status
Active Not Recruiting
Location
Queens University Belfast (Belfast Health and Social Care Trust)
Learn More & Join Trial